[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (5)

Search Parameters:
Keywords = BmPSI

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
9 pages, 543 KiB  
Article
Benchmarking Safety Indicators of Surgical Treatment of Brain Metastases Combined with Intraoperative Radiotherapy: Results of Prospective Observational Study with Comparative Matched-Pair Analysis
by Motaz Hamed, Anna-Laura Potthoff, Julian P. Layer, David Koch, Valeri Borger, Muriel Heimann, Davide Scafa, Gustavo R. Sarria, Jasmin A. Holz, Frederic Carsten Schmeel, Alexander Radbruch, Erdem Güresir, Niklas Schäfer, Patrick Schuss, Stephan Garbe, Frank A. Giordano, Ulrich Herrlinger, Hartmut Vatter, Leonard Christopher Schmeel and Matthias Schneider
Cancers 2022, 14(6), 1515; https://doi.org/10.3390/cancers14061515 - 16 Mar 2022
Cited by 13 | Viewed by 4253
Abstract
Intraoperative radiotherapy (IORT) of the operative cavity for surgically treated brain metastasis (BM) has gained increasing prominence with respect to improved local tumor control. However, IORT immediately performed at the time of surgery might be associated with increased levels of perioperative adverse events [...] Read more.
Intraoperative radiotherapy (IORT) of the operative cavity for surgically treated brain metastasis (BM) has gained increasing prominence with respect to improved local tumor control. However, IORT immediately performed at the time of surgery might be associated with increased levels of perioperative adverse events (PAEs). In the present study, we performed safety metric profiling in patients who had undergone surgery for BM with and without IORT in order to comparatively analyze feasibility of IORT as an adjuvant radiation approach. Between November 2020 and October 2021, 35 patients were surgically treated for BM with IORT at our neuro-oncological center. Perioperative complication profiles were collected in a prospective observational cohort study by means of patient safety indicators (PSIs), hospital-acquired conditions (HACs), and specific cranial-surgery-related complications (CSCs) as high-standard quality metric tools and compared to those of an institutional cohort of 388 patients with BM resection without IORT in a balanced comparative matched-pair analysis. Overall, 4 out of 35 patients (11%) with IORT in the course BM resection suffered from PAEs, accounting for 3 PSIs (9%) and 1 HAC (3%). Balanced matched-pair analysis did not reveal significant differences in the perioperative complication profiles between the cohorts of patients with and without IORT (p = 0.44). Thirty-day mortality rates were 6% for patients with IORT versus 8% for patients without IORT (p = 0.73). The present study demonstrates that IORT constitutes a safe and clinically feasible adjuvant treatment modality in patients undergoing surgical resection of BM. Full article
(This article belongs to the Special Issue Diagnosis and Treatment of Brain Metastases)
Show Figures

Figure 1

Figure 1
<p>Illustration of the matching procedure for patients with surgically treated BM dependent on the presence of IORT. (<b>A</b>) Comparative matched-pair analysis at a ratio of 1:3 identified 105 out of 388 patients with surgically treated BM without IORT that individually corresponded to the present series of 35 patients with surgically treated BM combined with IORT. Heat map is a color-coded illustration of the matching strategy of patients without IORT to individually matched IORT cases by means of age at admission, KPS at admission, CCI at admission, and tumor entity and solitary versus multiple BM as matching parameters. Red frames depict individually matched patients without IORT. (<b>B</b>) Visualization of obtained propensity scores for matched and unmatched patients with BM. (<b>C</b>) Love plot depicting the balance of the matching analysis for each matching parameter determined by the standardized mean differences. BM, brain metastasis; CCI, Charlson comorbidity index; IORT, intraoperative radiotherapy; KPS, Karnofsky performance score.</p>
Full article ">
8 pages, 361 KiB  
Article
Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases
by Matthias Schneider, Muriel Heimann, Christina Schaub, Lars Eichhorn, Anna-Laura Potthoff, Frank A. Giordano, Erdem Güresir, Yon-Dschun Ko, Jennifer Landsberg, Felix Lehmann, Alexander Radbruch, Katjana S. Schwab, Leonie Weinhold, Johannes Weller, Christian Wispel, Ulrich Herrlinger, Hartmut Vatter, Niklas Schäfer and Patrick Schuss
Cancers 2020, 12(11), 3209; https://doi.org/10.3390/cancers12113209 - 31 Oct 2020
Cited by 23 | Viewed by 2694
Abstract
Surgical resection is a key treatment modality for brain metastasis (BM). However, peri- and postoperative adverse events (PAEs) might be associated with a detrimental impact on postoperative outcome. We retrospectively analyzed our institutional database with regard to patient safety indicators (PSIs), hospital-acquired conditions [...] Read more.
Surgical resection is a key treatment modality for brain metastasis (BM). However, peri- and postoperative adverse events (PAEs) might be associated with a detrimental impact on postoperative outcome. We retrospectively analyzed our institutional database with regard to patient safety indicators (PSIs), hospital-acquired conditions (HACs) and specific cranial surgery-related complications (CSCs) as high-quality metric profiles for PAEs in patients who had undergone surgery for BM in our department between 2013 and 2018. The comorbidity burden was assessed by means of the Charlson comorbidity index (CCI). A multivariate analysis was performed to identify independent predictors for the development of PAEs after surgical resection of BM. In total, 33 patients (8.5%) suffered from PAEs after surgery for BM. Of those, 17 PSI, 5 HAC and 11 CSC events were identified. Multiple brain metastases (p = 0.02) and a higher comorbidity burden (CCI > 10; p = 0.003) were associated with PAEs. In-hospital mortality of patients suffering from a PAE was significantly higher than that of patients without a PAE (24% vs. 0.6%; p < 0.0001). Awareness of risk factors for postoperative complications enables future prevention and optimal response, particularly in vulnerable oncological patients. The present study identified the presence of multiple brain metastases and increased comorbidity burden associated with PAEs in patients suffering from BM. Full article
(This article belongs to the Special Issue Brain Metastases (Secondary Brain Tumor))
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Kaplan–Meier curves for overall survival (OS) dependent on the occurrence of postoperative adverse events (PAEs).</p>
Full article ">
13 pages, 2176 KiB  
Article
Spliceosomal Protein Gene BmSPX Regulates Reproductive Organ Development in Bombyx mori
by Yao Wang, Juan Li, Qiu-Xing Wan, Qin Zhao, Kai-Xuan Wang and Xing-Fu Zha
Int. J. Mol. Sci. 2020, 21(7), 2579; https://doi.org/10.3390/ijms21072579 - 8 Apr 2020
Cited by 4 | Viewed by 2912
Abstract
Sex determination and differentiation are nearly universal to all eukaryotic organisms, encompassing diverse systems and mechanisms. Here, we identified a spliceosomal protein gene BmSPX involved in sex determination of the lepidopeteran insect, Bombyx mori. In a transgenic silkworm line that overexpressed the [...] Read more.
Sex determination and differentiation are nearly universal to all eukaryotic organisms, encompassing diverse systems and mechanisms. Here, we identified a spliceosomal protein gene BmSPX involved in sex determination of the lepidopeteran insect, Bombyx mori. In a transgenic silkworm line that overexpressed the BmSPX gene, transgenic silkworm males exhibited differences in their external genitalia compared to wild-type males, but normal internal genitalia. Additionally, transgenic silkworm females exhibited a developmental disorder of the reproductive organs. Upregulation of BmSPX significantly increased the expression levels of sex-determining genes (BmMasc and BmIMP) and reduced the female-type splice isoform of Bmdsx, which is a key switch gene downstream of the sex-determination pathway. Additionally, co-immunoprecipitation assays confirmed an interaction between the BmSPX protein and BmPSI, an upstream regulatory factor of Bmdsx. Quantitative real-time PCR showed that BmSPX over-expression upregulated the expression of the Hox gene abdominal-B (Adb-B), which is required for specification of the posterior abdomen, external genitalia, and gonads of insects, as well as the genes in the Receptor Tyrosine Kinase (RTK) signaling pathway. In conclusion, our study suggested the involvement of BmSPX, identified as a novel regulatory factor, in the sex-determination pathway and regulation of reproductive organ development in silkworms. Full article
(This article belongs to the Special Issue Molecular Ecology, Physiology and Biochemistry of Insects 2.0)
Show Figures

Figure 1

Figure 1
<p>Establishment and phenotypic observation of Over-BmSPX transgenic strains. (<b>A</b>) Structure of piggyBac-BmSPX recombinant vector. 3xP3 and A4 promoters were used in the recombinant vector. The SV40 terminator was used to stop the transcription. pBacL and pBacR indicate the left and right terminal inverted repeats. 3xP3 indicate a hyperactive promoter containing three binding sites for Pax-6 homodimers in front of a TATA box. DsRed, <span class="html-italic">Discosoma</span> sp. Red Fluorescent Protein. SV40, Terminator of <span class="html-italic">Simian virus 40</span>. A4, Actin 4 promotor of <span class="html-italic">B. mori</span>. (<b>B</b>) The process of screening transgenic strains. The signal of DsRed in transgenic strain is indicated with red triangles. The positions without DsRed in Wild-type strain are indicated with white triangles. (<b>C</b>) Real-time PCR of <span class="html-italic">BmSpx</span> to confirm <span class="html-italic">BmSpx</span> over-expression. A value of <span class="html-italic">p</span> &lt; 0.05 was considered to be statistically significant (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001). (<b>D</b>) Phenotypic and gonad observations of Over-BmSPX strains. Wild-type-M and Wild-type-F indicate the male and female of wild type silkworm, respectively. Over-BmSPX-M and Over-BmSPX-F indicate the male and female of Over-BmSPX transgenic strains, respectively. An unknown thin needle rod in the middle of the gonad in Over-BmSPX-M is indicated with a blue arrow. Two sharp claspers in Over-BmSPX-M are indicated with a red arrow. The developmental disorders of two parts of alluring gland in Over-BmSPX-F are indicated with purple and green arrows.</p>
Full article ">Figure 2
<p>Expression levels of key factors in sex determination of Over-BmSPX transgenic strains. A value of <span class="html-italic">p</span> &lt; 0.05 was considered to be statistically significant (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001). (<b>A</b>) <span class="html-italic">BmMasc</span> expression level in Over-BmSPX transgenic strains. (<b>B</b>) <span class="html-italic">BmImp</span> expression level in Over-BmSPX transgenic strains. (<b>C</b>) Expression level of female-specific splicing of <span class="html-italic">Bmdsx</span> in Over-BmSPX transgenic strains. Wild-type-M and Wild-type-F indicate the male and female of wild type silkworm, respectively. Over-BmSPX-M and Over-BmSPX-F indicate the male and female of Over-BmSPX transgenic strains, respectively.</p>
Full article ">Figure 3
<p>BmSPX may participate in alternative splicing of <span class="html-italic">Bmdsx</span> as a splicing factor. (<b>A</b>) Co-immunoprecipitation (CO-IP) experiment between BmSPX and BmPSI. IP:Myc indicates that CO-IP experiment was carried out with Myc antibody. WB:Myc and WB:Flag indicate that Western Blot experiments were carried out with Myc antibody and Flag antibody, respectively. WCL, Whole cell lysate. (<b>B</b>) Sequence alignment of the RRM domain between BmSPX and its homologous protein SF3B4. RRM, RNA recognition motif. Black and grey indicate identical and similar amino acids, respectively. (<b>C</b>) The tertiary structure of BmSPX and SF3B4. (<b>D</b>) The electrophoretic mobility shift assay (EMSA) experiment between BmPSI and RNA probe CE1. MBP, Maltose binding protein.</p>
Full article ">Figure 4
<p>Expression levels of key factors in gonad development of Over-BmSPX transgenic strains. A value of <span class="html-italic">p</span> &lt; 0.05 was considered to be statistically significant (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001). (<b>A</b>) <span class="html-italic">BmTGIF</span> expression level in Over-BmSPX transgenic strains. (<b>B</b>) <span class="html-italic">BmAbd-B</span> expression level in Over-BmSPX transgenic strains. (<b>C</b>) Expression level of key factors, including in RTK, in Over-BmSPX transgenic strains. (<b>D</b>) Expression level of cyclin genes in Over-BmSPX transgenic strains. Wild-type-M and Wild-type-F indicate the male and female of wild type silkworm, respectively. Over-BmSPX-M and Over-BmSPX-F indicate the male and female of Over-BmSPX transgenic strains, respectively.</p>
Full article ">
18 pages, 2989 KiB  
Article
Bone Morphogenic Protein 2-Loaded Porous Silicon Carriers for Osteoinductive Implants
by Michal Rosenberg, Dekel Shilo, Leonid Galperin, Tal Capucha, Karim Tarabieh, Adi Rachmiel and Ester Segal
Pharmaceutics 2019, 11(11), 602; https://doi.org/10.3390/pharmaceutics11110602 - 12 Nov 2019
Cited by 21 | Viewed by 4267
Abstract
Bone morphogenetic proteins (BMPs) are probably the most important growth factors in bone formation and healing. However, the utilization of BMPs in clinical applications is mainly limited due to the protein poor solubility at physiological pH, rapid clearance and relatively short biological half-life. [...] Read more.
Bone morphogenetic proteins (BMPs) are probably the most important growth factors in bone formation and healing. However, the utilization of BMPs in clinical applications is mainly limited due to the protein poor solubility at physiological pH, rapid clearance and relatively short biological half-life. Herein, we develop degradable porous silicon (PSi)-based carriers for sustained delivery of BMP-2. Two different loading approaches are examined, physical adsorption and covalent conjugation, and their effect on the protein loading and release rate is thoroughly studied. The entrapment of the protein within the PSi nanostructures preserved its bioactivity for inducing osteogenic differentiation of rabbit bone marrow mesenchymal stems cells (BM-MSCs). BM-MSCs cultured with the BMP-2 loaded PSi carriers exhibit a relatively high alkaline phosphatase (ALP) activity. We also demonstrate that exposure of MSCs to empty PSi (no protein) carriers generates some extent of differentiation due to the ability of the carrier’s degradation products to induce osteoblast differentiation. Finally, we demonstrate the integration of these promising BMP-2 carriers within a 3D-printed patient-specific implant, constructed of poly(caprolactone) (PCL), as a potential bone graft for critical size bone defects. Full article
(This article belongs to the Special Issue Porous Silicon for Drug Delivery)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Schematic illustration of the fabrication of porous silicon (Psi) O<sub>2</sub> carriers and subsequent bone morphogenetic protein (BMP)-2 loading via (<b>A</b>) Physical adsorption, or (<b>B</b>) Covalent attachment. A thin Si wafer is subjected to anodization at 250 mA cm<sup>−2</sup> for 20 s, followed by thermal oxidation at 800 °C for 1 h to produce a PSiO<sub>2</sub> scaffold. For conjugation of the protein to the carrier, the PSiO<sub>2</sub> is modified using the following steps: (i) Reaction with (3-aminopropyl)triethoxysilane (APTES) to form an amine-terminated PSiO<sub>2</sub>; (ii) Introduction of succinic anhydride to yield a carboxylated surface; (iii) Carboxyl groups are activated into a reactive <span class="html-italic">N</span>-hydroxysulfosuccinimide sodium salt (NHS) ester intermediates by ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC) and NHS; (iv) Conjugation of BMP-2 is carried out through reaction of its primary amines with the amine-reactive NHS esters (note that the schematics are not drawn to scale).</p>
Full article ">Figure 2
<p>Characterization of the PSiO<sub>2</sub> carriers by electron microscopy and ATR-FTIR spectroscopy. (<b>A</b>,<b>B</b>) Top-view and cross-section micrographs of a typical PSiO<sub>2</sub> film etched at a current density of 250 mA cm<sup>−2</sup> for 20 s. (<b>C</b>) ATR-FTIR spectra of PSiO<sub>2</sub> following the different chemical modification steps performed for covalent conjugation of BMP-2: (i) Neat PSiO<sub>2</sub>; (ii) Amine-terminated surface after silanization with APTES; (iii) Carboxylated surface after modification with succinic anhydride; (iv) EDC/NHS activated surface; (v) BMP-2-conjugated PSiO<sub>2</sub>.</p>
Full article ">Figure 3
<p>(<b>A</b>) BMP-2 release from PSiO<sub>2</sub> carriers that were loaded by physical adsorption vs. covalent attachment of the protein. (<b>B</b>) Average BMP-2 loading and the corresponding accumulative release values for the two loading methods. Data represent mean ± SD, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 4
<p>Cell viability of BM-MSCs grown with different PSiO<sub>2</sub> carriers. The cells were cultured under one of the following conditions: (i) BMP-2-loaded PSiO<sub>2</sub> carriers which were loaded via physical adsorption or covalent conjugation; (ii) Empty PSiO<sub>2</sub> carriers (both neat PSiO<sub>2</sub> and chemically-modified PSiO<sub>2</sub> carriers); (iii) Supplementation of free BMP-2 solution at a concentration of 50 ng mL<sup>−1</sup>. Viability was tested on days 1, 3 and 6. The results are normalized to control untreated BM-MSCs and are presented as relative viability. Cell viability was determined by the Alamar Blue™ assay (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 5
<p>ALP staining of differentiated BM-MSCs after 14 days. (<b>A</b>) Representative light micrographs of cells exposed to (i) BMP-2-loaded PSiO<sub>2</sub> carriers via physical adsorption, (ii) Empty PSiO<sub>2</sub> carriers, (iii) BMP-2-loaded PSiO<sub>2</sub> carriers via covalent conjugation, (iv) Empty chemically-modified PSiO<sub>2</sub> carriers, (v) Free BMP-2 solution (100 ng mL<sup>−1</sup>) and (vi) no treatment (control, cells only). Scale bar = 100 µm. (<b>B</b>) Quantitative analysis of ALP activity, expressed as the average positively stained areas for each condition tested, *** indicates <span class="html-italic">p</span> ≤ 0.005.</p>
Full article ">Figure 6
<p>Design of the 3D printed scaffold for critical size bone defects. (<b>A</b>) 3D scanned rabbit mandible following bone resection and graft design using the freeform CAD program. (<b>B</b>) CAD design of the desired mesh (diameter of 10 mm) with an insert in its center to accommodate the PSiO<sub>2</sub> carriers. (<b>C</b>) The 3D-printed PCL mesh containing the 7 mm × 3 mm PSiO<sub>2</sub> carrier.</p>
Full article ">
11 pages, 7227 KiB  
Article
P-element Somatic Inhibitor Protein Binding a Target Sequence in dsx Pre-mRNA Conserved in Bombyx mori and Spodoptera litura
by Yao Wang, Qin Zhao, Qiu-Xing Wan, Kai-Xuan Wang and Xing-Fu Zha
Int. J. Mol. Sci. 2019, 20(9), 2361; https://doi.org/10.3390/ijms20092361 - 13 May 2019
Cited by 3 | Viewed by 3786
Abstract
Bombyx mori doublesex (Bmdsx) functions as a double-switch gene in the final step of the sex-determination cascade in the silkworm Bombyx mori. The P-element somatic inhibitor (PSI) protein in B. mori interacts with Bmdsx pre-mRNA in CE1 as an exonic [...] Read more.
Bombyx mori doublesex (Bmdsx) functions as a double-switch gene in the final step of the sex-determination cascade in the silkworm Bombyx mori. The P-element somatic inhibitor (PSI) protein in B. mori interacts with Bmdsx pre-mRNA in CE1 as an exonic splicing silencer to promote male-specific splicing of Bmdsx. However, the character of the interaction between BmPSI and Bmdsx pre-mRNA remains unclear. Electrophoretic mobility shift assay (EMSA) results showed that the four KH_1 motifs in BmPSI are all essential for the binding, especially the former two KH_1 motifs. Three active sites (I116, L127, and IGGI) in the KH_1 motif were found to be necessary for the binding through EMSA, circular dichroism (CD) spectroscopy, and isothermal titration calorimetry (ITC). The PSI homologous protein in S. litura (SlPSI) was purified and the binding of SlPSI and CE1 was verified. Compared with BmPSI, the mutant SlPSI proteins of I116 and IGGI lost their ability to bind to CE1. In conclusion, the binding of PSI and dsx pre-mRNA are generally conserved in both B. mori and S. litura. These findings provide clues for sex determination in Lepidoptera. Full article
(This article belongs to the Special Issue Molecular Ecology, Physiology and Biochemistry of Insects)
Show Figures

Figure 1

Figure 1
<p>Structure and binding ability of BmPSI and truncation proteins: (<b>a</b>) Comparison among BmPSI and four truncation proteins used for the binding experiment. “DUF” means “domain of unknown function”. (<b>b</b>) The dosage of these proteins. “NC” means “negative control”. (<b>c</b>) Binding ability of these proteins with CE1. Buffer and maltose binding protein (MBP) were set as the negative control and wild-type BmPSI was used as the positive control. (<b>d</b>) Cold competition electrophoretic mobility shift assay (EMSA) experiment between CE1 and BmPSI, MBP-ΔKH_1-3, and MBP-ΔKH_1-4 proteins.</p>
Full article ">Figure 2
<p>Important amino acids in the KH_1-1 motif of BmPSI: (<b>a</b>) Comparison among amino acid sequences of the KH_1 motifs in BmPSI. The black color represents that amino acids are completely identical. The gray color represents that partial amino acids are identical. Different colored boxes represent different potential key amino acid sites for the binding. (<b>b</b>) After the concentrations were adjusted uniformly, EMSA was performed on wild-type BmPSI and seven amino acid mutants of BmPSI.</p>
Full article ">Figure 3
<p>Two amino acids in the KH_1-1 motif of BmPSI play important roles in the binding with CE1: (<b>a</b>) The secondary structures of wild-type BmPSI and three kind of amino acid mutant proteins detected with circular dichroism (CD) spectroscopy. (<b>b</b>) The RNA binding affinity of three kinds of amino acid mutant proteins and wild-type BmPSI were assessed, showing different exports of isothermal titration calorimetry (ITC) under the same conditions.</p>
Full article ">Figure 4
<p>The combination of PSI and CE1 is conserved in <span class="html-italic">Spodoptera litura</span>: (<b>a</b>) A phylogenic tree based on the PSI of 10 species. (<b>b</b>) Conservation analysis of KH_1 motifs in these 10 species. The black color represents that amino acids are completely identical. The gray color represents that partial amino acids are identical. (<b>c</b>) SlPSI concentration gradient EMSA and cold competition EMSA.</p>
Full article ">Figure 5
<p>EMSA of wild-type SlPSI and three kinds of potentially key amino acid mutant SlPSI proteins. (<b>a</b>) MBP-BmPSI was set as the positive control. The signal intensity of the complex stood for the abilities of different proteins to interact with the CE1 probe. (<b>b</b>) Cold competition EMSA experiment between CE1 and SlPSI mutL127G.</p>
Full article ">
Back to TopTop